CP and ornithine carbamoyltransferase deficiency: Excess CP, produced in hepatocytes of patients with OTC deficiency, can exit mitochondria and enter pyrimidine biosynthesis leading to the accumulation of orotic acid, which is an intermediate of pyrimidine biosynthesis and a biomarker of OTC deficiency [10,11].